Cargando…
Adaptive immune resistance in HPV-associated head and neck squamous cell carcinoma
Human papillomavirus (HPV) types associated with head and neck cancer generally induce a robust immune response. Despite the establishment of such an inflammatory microenvironment, HPV is able to persist and promote malignant transformation. The PD-1:PD-L1 immune checkpoint may play a critical role...
Autor principal: | Pai, Sara I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3667901/ https://www.ncbi.nlm.nih.gov/pubmed/23762795 http://dx.doi.org/10.4161/onci.24065 |
Ejemplares similares
-
Immunotherapy of HPV-associated head and neck cancer: Critical parameters
por: Nizard, Mevyn, et al.
Publicado: (2013) -
The immune response in HPV(+) oropharyngeal cancer
por: King, Emma V, et al.
Publicado: (2014) -
Radiochemotherapy fosters a favorable pattern of inflammatory cells in head and neck tumors
por: Distel, Luitpold, et al.
Publicado: (2012) -
Single cell RNA-seq highlights a role for a partial EMT in head and neck cancer
por: Puram, Sidharth V., et al.
Publicado: (2018) -
A mitochondrial checkpoint to adaptive anticancer immunity
por: Kepp, Oliver, et al.
Publicado: (2023)